TargetKappa-type opioid receptor(Homo sapiens (Human))
Purdue Pharma L.P.; Shionogi & Co., Ltd.
US Patent
Purdue Pharma L.P.; Shionogi & Co., Ltd.
US Patent
Affinity DataKi: 425nMpH: 7.4Assay Description:Radioligand dose displacement assays used 0.4-0.8nM [3H]-U69,593 (NEN; 40 Ci/mmole) with 10-20 ug membrane protein (recombinant kappa opioid receptor...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)